ENHANCING
MUSCLE HEALTH
via
MITOCHONDRIALBIOENERGETICS
CelaMza
CelaMza is a fusion of “cellular” and the Sanskrit word “Amsha” (अंश), meaning a portion or spark of life. We are pioneering science-backed, patented solutions that target the root cause of age- related muscle decline, restoring cellular vitality and transforming healthy aging.Our innovative nutraceuticals and advanced therapies directly enhance mitochondrial function and energy production for unprecedented muscle health.
There is a Global Aging Crisis
The global population aged 65 and older is projected to reach 1.7 billion by 2054, creating an unprecedented demographic shift and healthcare challenge as more people face sarcopenia: age-related muscle loss that significantly impacts mobility and quality of life.
Nature Inspired Innovation
CelaMza provides groundbreaking nutraceuticals and therapeutics designed to directly combat age-related muscle decline.
PATENT PENDING
TEAM
DR. PADMAKUMAR NARAYANAN
FOUNDER & CHIEF SCIENTIFIC OFFICER
PRANAV NARAYANAN
CO-FOUNDER & EXECUTIVE DIRECTOR
CHARLES HENDRICKS
VP, PRODUCT & BUSINESS DEVELOPMENT
ADVISORS
RODRIGUE ROSSIGNOL
FOUNDER, CELLOMET
DR. PADMAKUMAR NARAYANAN
CHIEF SCIENTIFIC OFFICER
Dr. Padmakumar Narayanan brings over 25 years of unparalleled expertise in preclinical and clinical drug development, with a deep specialization in toxicology and safety assessment, directly relevant to CelaMza's innovative solutions. His robust scientific foundation is underpinned by his Doctor in Veterinary Medicine from Kerala Agricultural University, followed by a Master of Science in Small Animal Surgery from Tamil Nadu Veterinary and Animal Sciences University and Ph.D. in Immunophysiology/Immunotoxicology from Purdue University.Having held senior leadership roles at industry giants such as Ionis Pharmaceuticals, Amgen, Janssen, GlaxoSmithKline, and currently as Head of Preclinical & Clinical Development Sciences at Wave Life Sciences, Dr. Narayanan has a distinguished track record in guiding novel therapeutics, including oligonucleotide-based medicines, through rigorous safety evaluation from early discovery through clinical trials.His profound scientific rigor and extensive experience are invaluable in ensuring the safe and successful advancement of CelaMza's proprietary OPA-1 enhancing nutraceuticals and advanced ASO therapies, making him a cornerstone in our mission to restore cellular vitality and combat sarcopenia.
PRANAV NARAYANAN
EXECUTIVE DIRECTOR
An entrepreneur across diverse frontiers from web3 to human health, Pranav Narayanan turns groundbreaking ideas into tangible success. With a B.A. in Political Science (minors in Economics and Music Business Management) from Manhattanville College, he brings innovation to every venture.An experienced Co-Founder, Pranav drove R&D and design implementation for ADV3NT, a pioneering blockchain and distribution music platform— an aggregator for music to be collected and traded as real-world assets, currently valued at $2.5M for its technological infrastructure alone.His commercial acumen was honed over eight years at boutique marketing agency Digiwaxx Media, where he crafted go-to-market strategies for premium brands including Heineken, Monster Products, Asics, Puma, and Adidas. His team's campaigns drove hit records for major labels UMG, SONY Music, Warner, and their subsidiaries, driving artists into the cultural zeitgeist through strategic promotions and market positioning — artists like Morgan Heritage, Rihanna, Wyclef Jean and Walé to name a select few.A former collegiate / Pro-Amateur soccer player and physio-assistant, Pranav now coaches successfully in NYC, offering deep insight into sports performance, muscle health and athletic recovery. He's led the famous Brearley School to six champion titles, including their first NYSAIS State Championship in 2024. In addition, he helped raise $2M+ for Manhattan Soccer Club's new field development with the College of Mount Saint Vincent's in The Bronx.His operational foundation comes from a six year apprenticeship as Paralegal & Business Operations Manager at Pappalardo & Pappalardo, LLP, where he cut his teeth modernizing operations and strategically implemented AI tools for enhanced efficiency in case management and communications.At CelaMza, Pranav leverages this unique blend of entrepreneurial vision, commercial execution, wellness expertise, and operational discipline to translate cutting-edge science into consumer-friendly solutions in the rapidly expanding healthy aging market.
CHARLES HENDRICKS
VP, PRODUCT & BUSINESS DEVELOPMENT
Biotechnology executive with over 40 years of experience driving growth in product strategy, business development, and commercial operations. Charles has built and scaled organizations across RUO, GMP, and IVD environments, leading initiatives in Infectious Disease, Oncology, NGS, Regenerative Medicine, Diagnostics, Pharma, and Life Science Research.He has a proven track record of establishing commercial organizations from the ground up, restructuring underperforming functions, and implementing streamlined processes to align global teams and accelerate execution. His expertise spans business development, sales, marketing, go-to-market strategy, M&A, and cross-functional operations, giving him a comprehensive perspective on building sustainable, high-impact businesses.Charles’ career reflects deep knowledge of diverse regulatory frameworks—from Research Use Only (RUO) to GMP and IVD compliance—and the ability to translate scientific innovation into commercially viable solutions across the biotechnology and pharmaceutical landscape.
RODRIGUE ROSSIGNOL
SCIENTIFIC ADVISOR
Rodrigue's field of expertise is basic research on energy metabolism in physiology and pathology. He studies the molecular regulation of cell bioenergetics using genetic models of rare diseases and cancer. His expertise is used to develop Bioenergetic Modulation Therapies with the pharmaceutical industry, diagnostic assays, biomarker evaluation, and pathophysiology studies.